Evidence map›Paper›PMID 30187131›Full record

ArticleLung2018

Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis.

E Radzikowska, K Błasińska-Przerwa, E Wiatr, I Bestry, R Langfort, K Roszkowski-Śliż

Open access · hybridAbstract read
In one paragraph

Article in Lung, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Review
  4. Article
  5. Article
  6. Paediatric pulmonary Langerhans cell histiocytosis.Breathe (Sheffield, England) · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E RadzikowskaIII Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26 st., 01-138, Warsaw, Poland. e.radzikowska@wp.pl.ORCID http://orcid.org/0000-0002-2585-8594
K Błasińska-PrzerwaRadiology Department, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
E WiatrIII Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26 st., 01-138, Warsaw, Poland.
I BestryRadiology Department, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
R LangfortPathology Department, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
K Roszkowski-ŚliżIII Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26 st., 01-138, Warsaw, Poland.
Masih Daneshvari Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPneumothorax often develops in pulmonary Langerhans cell histiocytosis (PLCH), but some patients take a long time to be correctly diagnosed.

objectivesThis study assessed the frequency of pneumothorax in PLCH and analysed the role of chest computed tomography (CT) in the prompt diagnosis. PATIENTS AND MATERIAL: Of the 90 patients with PLCH seen from 2000 to 2015, 29 (32%) had pneumothorax as the initial finding. In this group, 18 (62%) patients were diagnosed within 1 month, whereas the diagnosis was delayed for 4-120 months in 11 (38%) patients.

resultsPatients who had pneumothorax as the initial sign of PLCH tended to be younger (mean age 27.7 ± 7.92 vs. 39.9 ± 13.21 years; P = 0.0001), male (69% vs. 43%; P = 0.028), smoked less (mean pack/years 8.4 ± 6.85 vs. 19 ± 17.16; P = 0.003), and had a significantly lower mean FVC (77.96 ± 19.62 vs. 89.47 ± 21.86% pred.; P = 0.015) and FEV

conclusionsPatients who had pneumothorax as the initial sign of PLCH were younger, more frequently men, and had greater respiratory impairment than those who had no pneumothorax. CT in patients with pneumothorax led to a correct diagnosis of this disease.

Indexed as

AdultAge FactorsDelayed DiagnosisFemaleForced Expiratory VolumeHistiocytosis, Langerhans-CellHumansMaleMiddle AgedPneumothoraxRecurrenceSex FactorsTomography, X-Ray ComputedVital CapacityYoung AdultComputed tomographyHistiocytosisPLCHPulmonary function test

Identifiers

PMID30187131
PMCPMC6244644
OpenAlexW2891147155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.